Cardiol Therapeutics Inc. (TSX: CRDL)
Canada
· Delayed Price · Currency is CAD 2.220
+0.040 (1.83%)
Nov 21, 2024, 4:00 PM EST
Cardiol Therapeutics Market Cap
Cardiol Therapeutics has a market cap or net worth of CAD 174.18 million as of November 21, 2024. Its market cap has increased by 129.75% in one year.
Market Cap
174.18M
Enterprise Value
158.46M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
2.22
Market Cap Chart
Since December 20, 2018, Cardiol Therapeutics's market cap has increased from 94.32M to 174.18M, an increase of 84.68%. That is a compound annual growth rate of 10.91%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bausch + Lomb Corporation | 9.76B |
| Bausch Health Companies Inc. | 4.39B |
| Curaleaf Holdings, Inc. | 2.35B |
| dentalcorp Holdings Ltd. | 1.84B |
| Tilray Brands, Inc. | 1.72B |
| Sienna Senior Living Inc. | 1.35B |
| WELL Health Technologies Corp. | 1.21B |
| Cronos Group Inc. | 1.09B |